10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-077904`
Period End Date	20120930
Filing Date	20121114
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	spex-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 55 Cash Flow Statement 42

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Trade accounts receivable, allowance (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Trade accounts receivable, allowance (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.17K	USD	Point-in-time
Property and equipment, accumulated depreciation (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$265.50K	USD	Point-in-time
Property and equipment, accumulated depreciation (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$316.44K	USD	Point-in-time
Patents, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$2.15K	USD	Point-in-time
Patents, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	-	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.58M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.65M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.02M	USD	Point-in-time
Trade accounts receivable, net of allowance of $0 and $8,174	`AccountsReceivableNetCurrent`	$286.06K	USD	Point-in-time
Trade accounts receivable, net of allowance of $0 and $8,174	`AccountsReceivableNetCurrent`	$156.44K	USD	Point-in-time
Preferred stock, series B shares issued	`PreferredStockSharesIssued`	5,250.00	shares	Point-in-time
Preferred stock, series B shares issued	`PreferredStockSharesIssued`	5,250.00	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$293.00	USD	Point-in-time
Preferred stock, series B shares outstanding	`PreferredStockSharesOutstanding`	1.00	shares	Point-in-time
Preferred stock, series B shares outstanding	`PreferredStockSharesOutstanding`	1.00	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$34.35K	USD	Point-in-time
Prepaid research expenses	`OtherPrepaidExpenseCurrent`	$209.78K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$120.43K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.50M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$24.17K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.53M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.86M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	208,207.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	155,150.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $316,438 and $265,502	`PropertyPlantAndEquipmentNet`	$91.48K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $316,438 and $265,502	`PropertyPlantAndEquipmentNet`	$42.15K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	207,806.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.56M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	154,723.00	shares	Point-in-time
Patents, net of accumulated amortization of $0 and $2,146	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Deposit	`DepositsAssetsNoncurrent`	$35.62K	USD	Point-in-time
Deposit	`DepositsAssetsNoncurrent`	$25.62K	USD	Point-in-time
Total assets	`Assets`	$5.66M	USD	Point-in-time
Total assets	`Assets`	$3.93M	USD	Point-in-time
Total assets	`Assets`	$5.63M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$213.42K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$270.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$454.39K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$549.82K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$80.88K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$72.87K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$748.69K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$892.68K	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$47.67K	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$44.88K	USD	Point-in-time
Total liabilities	`Liabilities`	$940.36K	USD	Point-in-time
Total liabilities	`Liabilities`	$793.57K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 2,000,000 shares authorized; 5,250 series B issued and 1 outstanding at September 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 2,000,000 shares authorized; 5,250 series B issued and 1 outstanding at September 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value, 2,500,000 shares authorized; 208,207 and 155,150 issued, 207,806 and 154,723 outstanding at September 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$1.55K	USD	Point-in-time
Common stock, $0.01 par value, 2,500,000 shares authorized; 208,207 and 155,150 issued, 207,806 and 154,723 outstanding at September 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$2.08K	USD	Point-in-time
Paid-in capital in excess of par value	`AdditionalPaidInCapital`	$42.32M	USD	Point-in-time
Paid-in capital in excess of par value	`AdditionalPaidInCapital`	$43.42M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$464.79K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$464.79K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-39.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-37.15M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.14M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$3.93M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.66M	USD	Point-in-time

Income Statement 55 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$198.46K	USD	1 Quarter
Revenue	`Revenues`	$690.82K	USD	3 Qtrs
Revenue	`Revenues`	$194.30K	USD	1 Quarter
Revenue	`Revenues`	$609.97K	USD	3 Qtrs
Direct costs	`DirectOperatingCosts`	$354.60K	USD	3 Qtrs
Direct costs	`DirectOperatingCosts`	$111.14K	USD	1 Quarter
Direct costs	`DirectOperatingCosts`	$336.71K	USD	3 Qtrs
Direct costs	`DirectOperatingCosts`	$87.40K	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$371.33K	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$1.13M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$617.47K	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$107.82K	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$742.14K	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$2.27M	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$2.31M	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$653.65K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.11M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$961.09K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.74M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.28M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.05M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-766.79K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.67M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-913.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$595.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.68K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$830.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.77K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$53.01K	USD	3 Qtrs
Gain on settlement of obligations	`GainLossRelatedToLitigationSettlement`	$845.00K	USD	3 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-765.96K	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-913.32K	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.15M	USD	3 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.67M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$14.48K	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.67M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.16M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-913.32K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-765.96K	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-3.69	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-13.31	USD	3 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-7.13	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-17.13	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-13.31	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-7.13	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-17.13	USD	3 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-3.69	USD	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	207,806.00	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	128,124.00	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	126,227.00	shares	3 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	200,547.00	shares	3 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	126,227.00	shares	3 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	207,806.00	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	200,547.00	shares	3 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	128,124.00	shares	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.67M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.16M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-913.32K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-765.96K	USD	1 Quarter
Gain on settlement of obligations	`GainLossRelatedToLitigationSettlement`	$845.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$50.94K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$52.87K	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-5.35K	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-8.17K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$40.35K	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-386.43K	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-103.75K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-316.04K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-404.51K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-492.83K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-151.99K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInOtherDeferredLiability`	$-24.67K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInOtherDeferredLiability`	$-2.80K	USD	3 Qtrs
Deferred compensation	`IncreaseDecreaseInDeferredCompensation`	$-305.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$8.01K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-102.20K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.09M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.31M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.85K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.60K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.60K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-4.85K	USD	3 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$2.55M	USD	3 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$1.06M	USD	3 Qtrs
Reverse stock split fractional shares payment	`PaymentsForReverseStockSplitFractionalSharesPayment`	$1.69K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.55M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.05M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-1.26M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-553.14K	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.58M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.65M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.91M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.02M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.58M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.65M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.91M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.02M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.